Physician profile
Boyd A Johnson
NPI 1215015482
$1,806.01
in general payments reported to CMS, 2019-2025
27 companies · $35.88 in 2025
The $35.88 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $365 · 2021: $638 · 2022: $242 · 2023: $144 · 2024: $33.06 · 2025: $35.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $258.61 | 2021-2023 | |
| Pfizer INC. | $208.76 | 2019-2022 | |
| Lilly USA, LLC | $158.16 | 2020-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $141.54 | 2019-2022 | |
| Amgen INC. | $124.39 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $107.03 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $99.67 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $98.72 | 2022-2023 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.05 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $77.69 | 2019-2022 | |
| Philips North America LLC | $67.65 | 2020 | |
| Novartis Pharmaceuticals Corporation | $43.62 | 2019 | |
| Mylan Specialty L.P. | $37.91 | 2019 | |
| Allergan, INC. | $33.39 | 2020 | |
| Exact Sciences Corporation | $30.17 | 2023 | Cologuard Collection Kit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $24.97 | 2021-2022 | |
| Biogen, INC. | $23.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.87 | 2022 | |
| Dexcom, INC. | $18.96 | 2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $18.70 | 2023 | Hillrom - Life 2000 Ventilation System |
| Vertex Pharmaceuticals Incorporated | $17.99 | 2024 | |
| Horizon Therapeutics Plc | $17.65 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.92 | 2025 | Rexulti |
| Novo Nordisk INC | $16.73 | 2021 | |
| Eisai INC. | $15.84 | 2020 | |
| Mimedx Group, INC. | $15.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.